IP Library › Granted Patent US 11,467,153
Granted Patent B2
US 11,467,153 · App. 17/393,107 · Granted Oct 11, 2022

Methods for processing nucleic acid molecules

Inventors: Zahra Kamila Belhocine (Fremont, CA); Jason Bell (Palo Alto, CA); Jerald Sapida (San Jose, CA); Katrina Sullivan-Bibee (Palo Alto, CA)
Assignee: 10X GENOMICS, INC.
G01N33/532C07K14/70539C12N15/1037C12N15/1055C12N15/1065C12N15/1075C12N15/11C12N15/85C12Q1/6804C12Q1/6806C12Q1/6818C12Q1/6827C12Q1/6881G01N33/505G01N33/5032G01N33/5304G01N33/5306G01N33/5308G01N33/548G01N33/54306G01N33/54366G01N33/56977G01N33/58C12N2310/20C12N2320/10C12Q2537/164C12Q2563/179C12Q2563/185C12Q2565/1015C40B30/04C40B50/06C40B70/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,467,153
App. No.
17/393,107
Granted
Oct 11, 2022
Kind
B2
Abstract

The present disclosure provides methods, systems, and kits for processing nucleic acid molecules. A method may comprise providing a template nucleic acid fragment (e.g., within a cell, cell bead, or cell nucleus) within a partition (e.g., a droplet or well) and subjecting the template nucleic acid fragment to one or more processes including a barcoding process and a single primer extension or amplification process. The processed template nucleic acid fragment may then be recovered from the partition and subjected to further amplification to provide material for subsequent sequencing analysis. The methods provided herein may permit simultaneous processing and analysis of both DNA and RNA molecules originating from the same cell, cell bead, or cell nucleus.

Claims (33)

1. A method comprising:

(a) providing a partition comprising (i) a biological particle comprising (I) a tagmented fragment of a deoxyribonucleic acid (DNA) molecule and (II) a ribonucleic acid (RNA) molecule, (ii) a first nucleic acid barcode molecule comprising a first barcode sequence, (iii) a second nucleic acid barcode molecule comprising a second barcode sequence, and (iv) a splint molecule, wherein said first nucleic acid barcode molecule comprises an overhang sequence, and wherein said splint molecule comprises a first sequence complementary to a sequence of said tagmented fragment and a second sequence complementary to said overhang sequence; and

(b) within said partition: (i) hybridizing said sequence of said tagmented fragment to said splint molecule, and hybridizing said overhang sequence of said first nucleic acid barcode molecule to said splint molecule to generate a first barcoded nucleic acid product comprising (I) said first barcode sequence or a complement thereof and (II) a sequence of said DNA molecule; and (ii) using said RNA molecule and said second nucleic acid barcode molecule to generate a second barcoded nucleic acid product comprising (I) said second barcode sequence or a complement thereof and (II) a complementary DNA (cDNA) sequence of said RNA molecule.

2. The method of claim 1 , wherein said biological particle is a cell, a cell bead, or a cell nucleus.

3. The method of claim 1 , further comprising lysing or permeabilizing said biological particle within said partition to provide access to said tagmented fragment and said RNA molecule.

4. The method of claim 1 , further comprising, prior to (a), contacting an open chromatin structure of said biological particle with a transposase-nucleic acid complex to yield said biological particle comprising said tagmented fragment.

5. The method of claim 4 , wherein said transposase-nucleic acid complex comprises a first adapter and a second adapter and wherein said tagmented fragment comprises a sequence of said DNA molecule flanked by said first adapter and said second adapter.

6. The method of claim 5 , wherein (b)(i) comprises hybridizing said splint molecule to said first adapter or said second adapter of said tagmented fragment, and ligating said first nucleic acid barcode molecule and said tagmented fragment to generate said first barcoded nucleic acid product.

7. The method of claim 5 , wherein said first adapter comprises a first transposon end sequence and a first primer sequence and wherein said second adapter comprises a second transposon end sequence and a second primer sequence.

8. The method of claim 7 , wherein (b)(i) comprises:

hybridizing said splint molecule to said first primer sequence or said second primer sequence of said tagmented fragment.

9. The method of claim 8 , further comprising, prior to said ligating, using a kinase to phosphorylate said tagmented fragment or said first nucleic acid barcode molecule.

10. The method of claim 9 , wherein said kinase is a polynucleotide kinase (PNK).

11. The method of claim 7 , wherein said first primer sequence or said second primer sequence is single stranded.

12. The method of claim 1 , further comprising subjecting said first barcoded nucleic acid product to one or more nucleic acid extension reactions.

13. The method of claim 12 , wherein said one or more nucleic acid extension reactions comprise attaching one or more functional sequences to said first barcoded nucleic acid product.

14. The method of claim 13 , wherein said one or more functional sequences comprise one or more flow cell adapter sequences, one or more sequencing primer sequences, one or more sequencing primer binding sequences, or one or more sample index sequences.

15. The method of claim 1 , wherein said second nucleic acid barcode molecule comprises a capture sequence complementary to said RNA molecule and wherein (b)(ii) comprises hybridizing said capture sequence to said RNA molecule and reverse transcribing said RNA molecule to generate said second barcoded nucleic acid product.

16. The method of claim 15 , wherein said capture sequence comprises a polythymine (poly-T) sequence.

17. The method of claim 1 , wherein said partition further comprises a primer comprising a sequence complementary to said RNA molecule and wherein (b)(ii) comprises hybridizing said primer to said RNA molecule, reverse transcribing said RNA molecule to generate a cDNA molecule, performing a template switching reaction onto said second nucleic acid barcode molecule, and extending said cDNA molecule to generate said second barcoded nucleic acid product.

18. The method of claim 17 , wherein said sequence complementary to said RNA molecule comprises a polythymine (poly-T) sequence.

19. The method of claim 17 , wherein said reverse transcribing comprises use of an enzyme with terminal transferase activity that appends a polynucleotide sequence to a 3′ end of said cDNA molecule and wherein said second nucleic acid barcode molecule comprises a sequence complementary to said polynucleotide sequence to facilitate said template switching reaction.

20. The method of claim 19 , wherein said polynucleotide sequence comprises a polycytosine (polyC) sequence and wherein said sequence complementary to said polynucleotide sequence comprises a polyguanine (polyG) sequence.

21. The method of claim 20 , wherein said polyG sequence comprises a ribonucleotide.

22. The method of claim 1 , wherein said partition is a droplet.

23. The method of claim 1 , wherein said partition is a well.

24. The method of claim 1 , wherein said first barcode sequence and said second barcode sequence are a same sequence.

25. The method of claim 1 , wherein said first barcode sequence and said second barcode sequence are different.

26. The method of claim 1 , wherein said tagmented fragment or said first nucleic acid barcode molecule comprises a 5′ phosphate.

27. The method of claim 1 , wherein said first nucleic acid barcode molecule and said second nucleic acid barcode molecule are coupled to a bead.

28. The method of claim 27 , wherein said bead is a gel bead.

29. The method of claim 27 , wherein said first nucleic acid barcode molecule and said second nucleic acid barcode molecule are releasable from said bead upon application of a stimulus.

30. The method of claim 27 , wherein said first nucleic acid barcode molecule and said second nucleic acid barcode molecule are each coupled to said bead via a labile bond.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2022
From: BELHOCINE, ZAHRA KAMILA; BELL, JASON; SAPIDA, JERALD; SULLIVAN-BIBEE, KATRINA
To: 10X GENOMICS, INC.
Reel/Frame 060771/0599 →
Continuity (3)
Continuation PCTUS2020018010 · Feb 12, 2020
Provisional Application 62804644 · Feb 12, 2019
Related Publication 20210364502A1 · Nov 25, 2021
Cited By (31)
US 12,188,014 US 12,209,271 US 12,235,262 US 12,249,402 US 12,264,316 US 12,264,411 US 12,275,993 US 12,305,239 US 12,312,640 US 12,365,893 US 12,391,975 US 12,391,976 US 12,398,262 US 12,411,132 US 12,416,102 US 12,467,088 US 12,473,585 US 12,480,158 US 12,534,721 US 12,534,760 US 12,553,074 US 12,600,961 US 12,606,860 US 12,612,666 US 12,612,714 US 12,624,384 US 12,655,450 US 12,686,949 US 12,692,536 US 12,729,402 US 12,735,810